Evaluation of Cost-Utility of Thoracic Interlaminar Epidural Injections

被引：0
|
作者：
Laxmaiah Manchikanti
Vidyasagar Pampati
Satya P. Sanapati
Mahendra R. Sanapati
Alan D. Kaye
Joshua A. Hirsch
机构：
[1] University of Louisville,Anesthesiology and Perioperative Medicine
[2] LSU Health Sciences Center,Department of Anesthesiology, School of Medicine
[3] Pain Management Centers of America,Department of Anesthesiology and Pharmacology, Toxicology, and Neurosciences
[4] Pain Management Centers of America,Neurointerventional Radiology, Neurointerventional Spine
[5] St Louis University,undefined
[6] Pain Management Centers of America,undefined
[7] Louisiana State University School of Medicine,undefined
[8] Massachusetts General Hospital and Harvard Medical School,undefined
来源：
Current Pain and Headache Reports | 2020年 / 24卷
关键词：
Thoracic pain; Thoracic epidural; Cost-utility analysis; Cost-effectiveness analysis; Quality-adjusted life year;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost Utility Analysis of Lumbar Interlaminar Epidural Injections In the Treatment of Lumbar Disc Herniation, Central Spinal Stenosis, and Axial or Discogenic Low Back Pain
    Manchikanti, Laxmaiah
    Pampati, Vidyasagar
    Benyamin, Ramsin M.
    Hirsch, Joshua A.
    PAIN PHYSICIAN, 2017, 20 (04) : 219 - 228
  • [22] Cervical Interlaminar Epidural Injections In The Treatment Of Cervical Disc Herniation, Post Surgery Syndrome, Or Discogenic Pain: Cost Utility Analysis From Randomized Trials
    Manchikanti, Laxmaiah
    Pampati, Vidyasagar
    Parr, Allan, III
    Manchikanti, Maanasa, V
    Sanapati, Mahendra R.
    Kaye, Alan D.
    Hirsch, Joshua A.
    PAIN PHYSICIAN, 2019, 22 (05) : 421 - 431
  • [23] COST-UTILITY ANALYSIS IN THE EVALUATION OF PERINATAL HEALTH-CARE
    DERHAM, R
    LANCET, 1986, 2 (8503): : 399 - 399
  • [24] EVALUATION OF THE COST-UTILITY OF THE YORK FAECAL CALPROTECTIN CARE PATHWAY
    Holmes, H.
    McMaster, J.
    Turvill, J.
    Davies, H.
    Vaines, V.
    VALUE IN HEALTH, 2019, 22 : S622 - S622
  • [25] EVALUATION OF STRATEGIES FOR THE PHYSICAL ACTIVITY PROMOTION: COST-UTILITY STUDY
    Sposito, L. A. C.
    Nakamura, P. M.
    Monteiro, H. L.
    Papini, C. B.
    Benedetti, T. R. B.
    Kokubun, E.
    REVISTA INTERNACIONAL DE MEDICINA Y CIENCIAS DE LA ACTIVIDAD FISICA Y DEL DEPORTE, 2021, 21 (83): : 607 - 621
  • [26] Economic evaluation of drug eluting stents: Cost-utility analysis
    Bischof, M.
    Briel, M.
    Bucher, H. C.
    Nordmann, A.
    VALUE IN HEALTH, 2006, 9 (06) : A354 - A354
  • [27] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Jesse Elliott
    Bláthnaid McCoy
    Tammy Clifford
    George A. Wells
    Doug Coyle
    PharmacoEconomics, 2018, 36 : 1253 - 1261
  • [28] Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis
    Elliott, Jesse
    McCoy, Blathnaid
    Clifford, Tammy
    Wells, George A.
    Coyle, Doug
    PHARMACOECONOMICS, 2018, 36 (10) : 1253 - 1261
  • [29] Evaluation of the Cost-Utility of the York Faecal Calprotectin Care Pathway
    Holmes, Hayden
    McMaster, Jessica
    Davies, Heather
    Vaines, Victoria
    Turvill, James
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (03) : 521 - 528
  • [30] COST-UTILITY ANALYSIS IN UROLOGY
    Fero, Katherine
    Sharma, Vidit
    Lec, Patrick
    Saigal, Christopher
    Chamie, Karim
    JOURNAL OF UROLOGY, 2021, 206 : E435 - E436
12345